Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home
197 items matching your search terms.
Filter the results.
Item type














New items since



Sort by relevance · date (newest first) · alphabetically
Der receives grant funding for pancreatic cancer research
by Mary Ruth published May 07, 2012 last modified May 08, 2012 09:56 AM — filed under: , ,
Channing Der, PhD, Sarah Graham Kenan Professor of Pharmacology, received a two-year $200,000 American Association for Cancer Research Innovative grant from the Pancreatic Cancer Action Network. His grant will fund research on the mechanism of ERK inhibition resistance and ERK-dependent pancreatic cancer.
Located in News / 2012 News
DeSimone elected into National Academy of Sciences
by Mary Ruth published May 03, 2012 last modified May 03, 2012 10:09 AM — filed under: ,
Dr. Joseph DeSimone, PhD, Chancellor's Eminent Professor of Chemistry at the University of North Carolina at Chapel Hill, has been elected into the National Academy of Sciences, one of the highest honors that a U.S. scientist or engineer can receive.
Located in News / 2012 News
DeSimone talks about research, developing new medicines
by Mary Ruth published Mar 12, 2012 last modified Mar 13, 2012 09:17 AM — filed under: , ,
Located in News / 2012 News
Dibbert elected president of National Association of Cancer Center Development Officers
by Mary Ruth published Jun 13, 2012 last modified Jun 21, 2012 09:28 AM — filed under: ,
Chapel Hill, NC – Debbie C. Dibbert, Director of External Affairs at UNC Lineberger Comprehensive Cancer Center, has been elected president of the National Association of Cancer Center Development Officers (NACCDO). She will serve a two-year term.
Located in News / 2012 News
Diseases of aging map to a few ‘hotspots’ on the human genome
by Mary Ruth published Sep 19, 2012 last modified Sep 20, 2012 11:23 AM — filed under: ,
Chapel Hill, NC –Researchers have long known that individual diseases are associated with genes in specific locations of the genome.
Located in News / 2012 News
Dittmer selected to serve as chair of AIDS-Associated Opportunistic Infections and Cancer Study Section
by Mary Ruth published Jul 21, 2012 last modified Jul 20, 2012 09:28 AM — filed under: ,
Dirk Dittmer, PhD, professor of microbiology and immunology, has been selected to serve as chair of the AIDS-Associated Opportunistic Infections and Cancer Study Section, for the Center for Scientific Review, a program of the National Institutes of Health.
Located in News / 2012 News
Diving into the Summer Olympics, UNC Lineberger employee's special connection
by Mary Ruth published Jul 23, 2012 last modified Jul 25, 2012 10:59 AM — filed under: ,
Ana McCrory of the Tissue Culture Facility will be making a special trip to London in July. She, her husband, Doug, their son, Lucas, and other family members are traveling to cheer on her son, Nick, who is a member of the 11-member US diving team for the 2012 Summer Olympics.
Located in News / 2012 News
DNA replication protein also has a role in mitosis, cancer
by Mary Ruth published May 14, 2012 last modified May 14, 2012 02:21 PM — filed under: ,
The finding presents a possible explanation for why so many cancers possess not just genomic instability, but also more or less than the usual 46 DNA-containing chromosomes.
Located in News / 2012 News
Dr. Hy Muss Named a 2012 Brinker Award winner for scientific distinction
by Mary Ruth published Sep 28, 2012 last modified Oct 01, 2012 11:24 AM — filed under: , ,
DALLAS -- An American clinician-scientist and an Israeli researcher whose work has led to more personalized treatments for breast cancer are being honored as this year’s winners of the prestigious Susan G. Komen for the Cure® Brinker Awards for Scientific Distinction in Basic Science and Clinical Research, the highest awards of merit given by the world’s leading breast cancer organization.
Located in News / 2012 News
Dr. Lisa Carey authors editorial on neoadjuvant trials for breast cancer
by Mary Ruth published Jun 15, 2012 last modified Jun 22, 2012 02:45 PM — filed under: , ,
Lisa Carey, MD, authored an editorial, titled “Neoadjuvant Trials of Human Epidermal Growth Factor Receptor 2 Targeting: How Many Drugs Do We Need?”
Located in News / 2012 News